Related Experiment Video
Updated: Mar 8, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
MicroRNA-194 represses glioma cell epithelial‑to‑mesenchymal transition by targeting Bmi1
Xi Zhang1, Chunyan Wei2, Jin Li1
1Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Abstract:
MicroRNA-194 (miR-194) is frequently dysregulated in many types of cancer. However, the function of miR-194 in glioma remains unknown. In the present study, we aimed to investigate the biological functions of miR-194 in glioma and the potential molecular mechanism of miR-194 involved in glioma progression. We found that miR-194 expression was significantly reduced in glioma specimens and cell lines, as detected by real-time quantitative polymerase chain reaction (RT-qPCR) analysis. The overexpression of miR-194 inhibited while the suppression of miR-194 promoted cell migration, invasion and epithelial mesenchymal transition (EMT) in glioma cells. Bioinformatics analysis showed that the B cell-specific moloney murine leukemia virus insertion site 1 (Bmi1) was a direct target of miR-194, which was validated by dual-luciferase reporter assay, RT-qPCR and western blot analysis. The restoration of Bmi1 expression significantly abrogated the suppressive effect of miR-194 on glioma cell EMT. Taken together, the present study suggests that miR-194 inhibits glioma cell EMT by targeting Bmi1 providing novel insights into understanding the pathogenesis of glioma. The restoration of miR-194 may be a potential therapeutic strategy for glioma treatment.
Insights
MicroRNA-194 (miR-194) is downregulated in glioma, inhibiting cancer cell migration and invasion. It targets Bmi1, suggesting miR-194 restoration as a potential glioma therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-194 (miR-194) is often dysregulated in various cancers.
- The specific role of miR-194 in glioma pathogenesis is currently unknown.
Purpose of the Study:
- To investigate the biological functions of miR-194 in glioma.
- To elucidate the molecular mechanism underlying miR-194's role in glioma progression.
Main Methods:
- Real-time quantitative polymerase chain reaction (RT-qPCR) to assess miR-194 expression.
- Cell migration, invasion, and epithelial-mesenchymal transition (EMT) assays.
- Bioinformatics analysis, dual-luciferase reporter assay, RT-qPCR, and western blot to validate Bmi1 as a direct target of miR-194.
Main Results:
- miR-194 expression was significantly decreased in glioma tissues and cell lines.
- Overexpression of miR-194 suppressed glioma cell migration, invasion, and EMT.
- Bmi1 was identified and validated as a direct target of miR-194.
- Restoration of Bmi1 expression reversed the inhibitory effects of miR-194 on glioma cell EMT.
Conclusions:
- miR-194 inhibits glioma cell EMT by directly targeting Bmi1.
- This study provides novel insights into glioma pathogenesis.
- Restoring miR-194 levels may represent a potential therapeutic strategy for glioma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

